Skip to main content
Caplight Logo









Paradigm Health

Paradigm Health

Private
New York City, New YorkHealthcare & Life Scienceshttps://www.paradigmhealth.ai/

Last Round

Series B

Dec 4, 2025

Total Funding Raised

$359M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Paradigm Health is a healthtech company that provides an AI-powered platform to enable equitable access to clinical trials for patients while enhancing trial efficiency for healthcare providers.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, EHR & EMR, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

clinical trial softwareEHR integrationclinical research networkclinical trial techpatient matchingeSourceelectronic health recordEHRmedical AIclinical trial automationCROclinical research organizationai health techtrial site operationseCRFhealthcare vertical SaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Paradigm Health Comparables

Compare Paradigm Health with similar companies based on industry and business-model similarity.

Paradigm Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BEKhealth
81%
SiteRx
81%
eMed
78%

Paradigm Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BDec 4, 2025
Series BDec 4, 2025
Series AJan 25, 2023

Paradigm Health Investors

Notable investors and investment history

Paradigm Health investors
InvestorRounds
Magnetic VenturesSeries A
GVSeries A, Series B
ARCH Venture PartnersSeries A, Series B
Lux CapitalSeries A, Series B
ARCH Venture PartnersSeries A, Series B
BrightEdgeSeries A, Series B
General CatalystSeries B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 4, 2025

    $78M round led by ARCH Venture Partners

Paradigm Health Filings

Explore SEC and related filing metadata, where available.

Paradigm Health filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Paradigm Health's valuation, stock price, and market status.

Is Paradigm Health a public or private company?

Paradigm Health is a private company.

What is the current stock price of Paradigm Health?

Paradigm Health is a private company with no public stock price. No recent secondary market data is available.

How much is Paradigm Health worth (valuation)?

Valuation information for Paradigm Health is not publicly available.

Can I buy Paradigm Health stock?

Paradigm Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Paradigm Health's last funding round?

Paradigm Health's most recent funding round was Series B on December 4, 2025.

Who are the main investors in Paradigm Health?

Key investors in Paradigm Health include ARCH Venture Partners, General Catalyst.

Will Paradigm Health IPO soon?

No public IPO plans have been announced for Paradigm Health.

How can I track Paradigm Health secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Paradigm Health's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Year Founded2021
Last FundingDec 4, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?